Abstract
Retinal vein occlusion (RVO) is the second most common retinal vascular disorder, after diabetic retinopathy. Most patients suffering RVO develop some degree of visual loss consequent to retinal complications such as edema and microhemorrhages. Even if some risk factors for RVO have been identified, the clinical outcome of RVO remains highly unpredictable because studies investigating potential prognostic markers for visual improvement are lacking. Cyanocobalamin belongs to the group of B vitamins and plays a role in homocysteine metabolism; however, cyanocobalamin deficiency associates with an increase of some toxic bioproducts involved in endothelial injury and platelet activation independent of homocysteine levels. We retrospectively evaluated the levels of vitamin B12 at diagnosis in 203 patients with RVO, and in a parallel cohort of 120 age- and sex-matched patients without RVO from an internal medicine ward, and correlated them with visual outcome at follow-up (median time 150 days, IQR 30–210). In patients with RVO, vitamin B12 levels at diagnosis were significantly lower than in controls and independently predicted worse clinical outcome at multivariate analysis (OR 3.2; CIs 1.2–8.2; p = 0.015). Our data suggest the opportunity to prospectively evaluate the effect on visual outcome of cyanocobalamin supplementation in RVO patients.
Similar content being viewed by others
References
Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY, International Eye Disease (2010) The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117:313–319
Pacella F, Bongiovanni G, Malvasi M, Trovato Battagliola E, Pistone A, Scalinci SZ, Basili S, La Torre G, Pacella E (2020) Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion. Clin Ter 17:e534–e538
Wu CY, Riangwiwat T, Limpruttidham N, Rattanawong P, Rosen RB, Deobhakta A (2019) Association of retinal vein occlusion with cardiovascular events and mortality: a systematic review and meta-analysis. Retina 39:1635–1645
Song P, Xu Y, Zha M, Zhang Y, Rudan I (2019) Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health 9:010427
Prisco D, Marcucci R (2002) Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 32:308–311
McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen HP, Wong TY (2010) Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117:1113–1123
Ageno W, Beyer-Westendorf J, Garcia DA, Lazo-Langner A, McBane RD, Paciaroni M (2016) Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis 41:129–143
Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, Nguyen HP, Wang JJ, Wong TY (2010) Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117:1094–1101
Rong AJ, Swaminathan SS, Vanner EA, Parrish RK 2nd (2019) Predictors of neovascular glaucoma in central retinal vein occlusion. Am J Ophthalmol 204:62–69
Prisco D, Marcucci R, Bertini L, Gori AM (2002) Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 13:163–169
Marcucci R, Sofi F, Grifoni E, Sodi A, Prisco D (2011) Retinal vein occlusions: a review for the internist. Intern Emerg Med 6:307–314
Gouliopoulos N, Siasos G, Moschos MM, Oikonomou E, Rouvas A, Bletsa E, Stampouloglou P, Siasou G, Paraskevopoulos T, Vlasis K, Marinos G, Tousoulis D (2020) Central retinal vein occlusion associated with platelet activation. Vasc Med 25:302–308
Citirik M (2019) Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion. Ther Adv Ophthalmol 11:2515841419864844
Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ (2005) Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 93:1021–1026
McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U (2009) Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology 116:1778–1787
Chua B, Kifley A, Wong TY, Mitchell P (2005) Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 139:181–182
Green R, Allen LH, Bjorke-Monsen AL, Brito A, Gueant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM, Yajnik C (2017) Vitamin B12 deficiency. Nat Rev Dis Primers 3:17040
Palareti G, Salardi S, Piazzi S, Legnani C, Poggi M, Grauso F, Caniato A, Coccheri S, Cacciari E (1986) Blood coagulation changes in homocystinuria: effects of pyridoxine and other specific therapy. J Pediatr 109:1001–1006
Dichek DA, Anderson J, Kelly AB, Hanson SR, Harker LA (1996) Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 93:301–309
Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM (1993) Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 13:1327–1333
Rodgers GM, Kane WH (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909–1916
Ratnoff OD (1968) Activation of Hageman factor by L-homocystine. Science 162:1007–1009
Graeber JE, Slott JH, Ulane RE, Schulman JD, Stuart MJ (1982) Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism. Pediatr Res 16:490–493
Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G (2000) Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 26:243–254
Andres E, Affenberger S, Federici L, Korganow AS (2006) Pseudo-thrombotic microangiopathy related to cobalamin deficiency. Am J Med 119:e3
Harada Y, Komori I, Morinaga K (2018) Shimizu T (2018) Microangiopathic haemolytic anaemia with thrombocytopenia induced by vitamin B12 deficiency long term after gastrectomy. BMJ Case Rep 2018:bcr2018225915
Veit K (2017) Pseudothrombotic microangiopathy and vitamin B12 deficiency in pernicious anemia. Proc (Bayl Univ Med Cent) 30:346–347
Tran PN, Tran MH (2018) Cobalamin deficiency presenting with thrombotic microangiopathy (TMA) features: a systematic review. Transfus Apher Sci 57:102–106
Oger E, Lacut K, Le Gal G, Couturaud F, Guenet D, Abalain JH, Roguedas AM, Mottier D, Edith Collaborative Study G (2006) Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost 4:793–799
Napal Lecumberri JJ, Gonzalez Bores P, Cuesta Marin A, Caballero Avendano FA, Olmos Martinez JM, Hernandez Hernandez JL (2021) Lipid profile and serum folate, vitamin B12 and homocysteine levels in patients with retinal vein occlusion. Clin Investig Arterioscler Clin Investig Arterioscler 33(4):169–174
Minniti G, Calevo MG, Giannattasio A, Camicione P, Armani U, Lorini R, Piana G (2014) Plasma homocysteine in patients with retinal vein occlusion. Eur J Ophthalmol 24:735–743
Sofi F, Marcucci R, Bolli P, Giambene B, Sodi A, Fedi S, Menchini U, Gensini GF, Abbate R, Prisco D (2008) Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 198:223–227
Kazantzis D, Theodossiadis P, Kroupis C, Theodossiadis G, Chatziralli I (2021) Vitamin B12 and folate as risk factors for retinal vein occlusion: a meta-analysis. Klin Monbl Augenheilkd. https://doi.org/10.1055/a-1473-5897
Langan RC, Goodbred AJ (2017) Vitamin B12 deficiency: recognition and management. Am Fam Physician 96:384–389
Khayat M, Williams M, Lois N (2018) Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion. Surv Ophthalmol 63:816–850
Ageno W, Cattaneo R, Manfredi E, Chelazzi P, Venco L, Ghirarduzzi A, Cimino L, Filippucci E, Ricci AL, Romanelli D, Incorvaia C, D’Angelo S, Campana F, Molfino F, Scannapieco G, Rubbi F, Imberti D (2010) Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study. Thromb Res 125:137–141
Bucciarelli P, Passamonti SM, Gianniello F, Artoni A, Martinelli I (2017) Thrombophilic and cardiovascular risk factors for retinal vein occlusion. Eur J Intern Med 44:44–48
Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE, Hubbard LD, Siscovick DS, Sharrett AR (2005) Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 112:540–547
Paciullo F, Giannandrea D, Virgili G, Cagini C, Gresele P (2021) Role of increased lipoprotein (a) in retinal vein occlusion: a systematic review and meta-analysis. TH Open 5(3):e295–e302
McMullin MF, Young PB, Bailie KE, Savage GA, Lappin TR, White R (2001) Homocysteine and methylmalonic acid as indicators of folate and vitamin B12 deficiency in pregnancy. Clin Lab Haematol 23:161–165
Stabler SP (2013) Clinical practice. Vitamin B12 deficiency. N Engl J Med 368(2):149–160
Seal EC, Metz J, Flicker L, Melny J, Seal EC et al (2002) A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc 50(1):146–151
Metz J, Bell AH, Flicker L, Bottiglieri T, Ibrahim J, Seal E, Schultz D, Savoia H, McGrath KM, Metz J et al (1996) The significance of subnormal serum vitamin B12 concentration in older people: a case control study. J Am Geriatr Soc 44(11):1355–1361
Favrat B, Vaucher P, Herzig L, Burnand B, Ali G, Boulat O, Bischoff T, Verdon F, Favrat B et al (2011) Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial. BMC Fam 12:2
Di Capua M, Coppola A, Albisinni R, Tufano A, Guida A, Di Minno MN, Cirillo F, Loffredo M, Cerbone AM (2010) Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis 30:16–22
Masselli E, Pozzi G, Vaccarezza M, Mirandola P, Galli D, Vitale M, Carubbi C, Gobbi G (2020) ROS in platelet biology: functional aspects and methodological insights. Int J Mol Sci 21:4866
Marcinkowska A, Cisiecki S, Rozalski M (2021) Platelet and thrombophilia-related risk factors of retinal vein occlusion. J Clin Med 10:3080
Elin RJ, Winter WE (2001) Methylmalonic acid: a test whose time has come? Arch Pathol Lab Med 125:824–827
Dropinski J (2011) Cardiovascular and thrombophilic risk factors in patients with central retinal vein occlusion. J Thromb Haemost 9:874–875
Khan Z, Almeida DR, Rahim K, Belliveau MJ, Bona M, Gale J (2013) 10-Year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis. Can J Ophthalmol 48(1):40-45.e1
Dali-Youcef N, Andres E (2009) An update on cobalamin deficiency in adults. QJM 102:17–28
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
The study protocol was conducted in accordance with the Declaration of Helsinki.
Conflict of interest
Authors declare no conflicts of interest.
Human and animal rights
This article does not contain any studies with animals performed by any of the authors. Patients data were anonymized and analyzed in aggregate form.
Informed consent
Informed consent for the utilization of clinical data for scientific aims was acquired at the time of hospital admission.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Paciullo, F., Menduno, P.S., Tucci, D. et al. Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study. Intern Emerg Med 17, 1065–1071 (2022). https://doi.org/10.1007/s11739-021-02905-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-021-02905-7